Is customization in antidepressant prescribing associated with acute-phase treatment adherence?

Journal of Pharmaceutical Health Services Research

Volumn 3, Issue 1, 2012, Pages 11-16

  Merrick, Elizabeth L ^a   Hodgkin, Dominic ^a   Panas, Lee ^a   Soumerai, Stephen B ^b   Ritter, Grant ^a  

^a BRANDEIS UNIVERSITY   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Antidepressants; Customization; Depression treatment; Prescribing patterns; Quality of care

Indexed keywords

ANTIDEPRESSANT AGENT; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEPRESSION; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; ETHNICITY; FEMALE; HEALTH CARE QUALITY; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEDICAID; MEDICARE; MENTAL HEALTH; PATIENT CARE; PATIENT COMPLIANCE; PRESCRIPTION; PRIORITY JOURNAL; QUALITY CONTROL; RACE DIFFERENCE; SEX DIFFERENCE;

EID: 84857072614     PISSN: 17598885     EISSN: 17598893     Source Type: Journal    
DOI: 10.1111/j.1759-8893.2011.00068.x     Document Type: Article

References (25)

1. Institute of Medicine. Improving the Quality of Health Care for Mental and Substance-Use Conditions. Washington DC: National Academies Press, 2006.
2. Donaghue J, Taylor DM. Suboptimal use of antidepressants in the treatment of depression. CNS Drugs 2000; 13: 365-383.
3. Weilburg JB etal. Evaluation of the adequacy of outpatient antidepressant treatment. Psychiatr Serv 2003; 54: 1233-1239.
4. Agency for Health Care Policy and Research. Depression Guideline Panel, Vol 2: Treatment of Major Depression, Clinical Practice Guideline. No. 5.Rockville, MD: US Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research, 1993.
5. American Psychiatric Association. Treatment of Patients with Major Depressive Disorder, 3rd edn. Arlington, VA: American Psychiatric Association, 2010.
6. National Committee for Quality Assurance (NCQA). State of Health Care Quality. Washington, DC: NCQA, 2010.
7. Akincigil A etal. Adherence to antidepressant treatment among privately insured patients diagnosed with depression. Med Care 2007; 45: 363-369.
8. Charbonneau A etal. Measuring the quality of depression care in a large integrated health system. Med Care 2003; 41: 669-680.
9. Lingam R, Scott J. Treatment non-adherence in affective disorders. Acta Psychiatr Scand 2002; 105: 164-172.
10. Insel T. Translating scientific opportunity into pubulic health impact: a strategic plan for research on mental illness. Arch Gen Psychiatry 2009; 66: 128-133.
11. Qaseem A etal. Using second-generation antidepressants to treat depressive disorders: a clinical practice guideline from the American College of Physicians. Ann Intern Med 2008; 149: 725-733.
12. Smoller JW, Nierenberg AA. Small numbers, big impact. Harv Rev Psychiatry 1999; 7: 109-113.
13. Frank RG, Zeckhauser RJ. Custom-made versus ready-to-wear treatments: behavioral propensities in physicians' choices. J Health Econ 2007; 26: 1101-1127.
14. Taub AAL etal. The diversity of concentrated prescribing behavior: an application to antipsychotics. NBER Working Paper 16823, February 2011. (accessed 11 April 2011).
15. Kaiser Family Foundation. Dual Eligibiles: medicaid's role for low-income medicare beneficiaries. 2010; (accessed 28 September 2011).
16. National Committee for Quality Assurance (NCQA). HEDIS 2009 Technical Specifications (Vol.2). Washington, DC: NCQA, 2008.
17. Coscelli A, Shum M. An empirical model of learning and patient spillovers in new drug entry. J Econ 2004; 122: 213-246.
18. De Jong JD etal. Do decision support systems influence variation in prescription? BMC Health Serv Res 2009; 9: 20.
19. Stern S, Trajtenberg M. Empirical implications of physician authority in pharmaceutical decisionmaking. NBER Working Paper 6851, December 1998. (accessed 29 September 2011).
20. Olfson M etal. Continuity of antidepressant treatment for adults with depression in the United States. Am J Psychiatry 2006; 163: 101-108.
21. Rollman BL etal. Race, quality of depression care, and recovery from major depression in a primary care setting. Gen Hosp Psychiatry 2002; 24: 381-390.
22. Deyo RA etal. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992; 45: 613-619.
23. StataCorp. Stata Statistical Software, Release 11. College Station, TX: StataCorp LP, 2009.
24. Busch SH etal. Measuring quality of pharmacotherapy for depression in a national health care system. Med Care 2004; 42: 532-542.
25. Joo JH etal. Predictors of adequacy of depression management in the primary care setting. Psychiatr Serv 2005; 56: 1524-1528.